GSK-201832

Study Sponsor: GSK

Study Title

201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects with Asthma and Exercise-Induced Bronchoconstriction

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol

Sponsor Identification Number

201832

Trial Registry Identification Number(#'s)

NCT02730351 2017-001516-11

Medical Condition

Asthma

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=201832

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02730351

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2017-001516-11

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

April 2019